Global and United States Poliomyelitis Vaccine Market Report & Forecast 2024-2031

Report ID: 1827084 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Poliomyelitis Vaccine Product Introduction
    1.2 Global Poliomyelitis Vaccine Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Poliomyelitis Vaccine Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Poliomyelitis Vaccine Sales in Volume for the Year 2017-2028
    1.3 United States Poliomyelitis Vaccine Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Poliomyelitis Vaccine Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Poliomyelitis Vaccine Sales in Volume for the Year 2017-2028
    1.4 Poliomyelitis Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Poliomyelitis Vaccine in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Poliomyelitis Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Poliomyelitis Vaccine Market Dynamics
        1.5.1 Poliomyelitis Vaccine Industry Trends
        1.5.2 Poliomyelitis Vaccine Market Drivers
        1.5.3 Poliomyelitis Vaccine Market Challenges
        1.5.4 Poliomyelitis Vaccine Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Poliomyelitis Vaccine Market Segment by Type
        2.1.1 Poliomyelitis Vaccine Ⅰ
        2.1.2 Poliomyelitis Vaccine Ⅱ
        2.1.3 Poliomyelitis Vaccine Ⅲ
        2.1.4 Oral Poliomyelitis Vaccine
    2.2 Global Poliomyelitis Vaccine Market Size by Type
        2.2.1 Global Poliomyelitis Vaccine Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Poliomyelitis Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Poliomyelitis Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Poliomyelitis Vaccine Market Size by Type
        2.3.1 United States Poliomyelitis Vaccine Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Poliomyelitis Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Poliomyelitis Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Poliomyelitis Vaccine Market Segment by Application
        3.1.1 VAPP
        3.1.2 VDPV
    3.2 Global Poliomyelitis Vaccine Market Size by Application
        3.2.1 Global Poliomyelitis Vaccine Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Poliomyelitis Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Poliomyelitis Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Poliomyelitis Vaccine Market Size by Application
        3.3.1 United States Poliomyelitis Vaccine Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Poliomyelitis Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Poliomyelitis Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Poliomyelitis Vaccine Competitor Landscape by Company
    4.1 Global Poliomyelitis Vaccine Market Size by Company
        4.1.1 Top Global Poliomyelitis Vaccine Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Poliomyelitis Vaccine Revenue by Manufacturer (2017-2022)
        4.1.3 Global Poliomyelitis Vaccine Sales by Manufacturer (2017-2022)
        4.1.4 Global Poliomyelitis Vaccine Price by Manufacturer (2017-2022)
    4.2 Global Poliomyelitis Vaccine Concentration Ratio (CR)
        4.2.1 Poliomyelitis Vaccine Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Poliomyelitis Vaccine in 2021
        4.2.3 Global Poliomyelitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Poliomyelitis Vaccine Manufacturing Base Distribution, Product Type
        4.3.1 Global Poliomyelitis Vaccine Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Poliomyelitis Vaccine Product Type
        4.3.3 Date of International Manufacturers Enter into Poliomyelitis Vaccine Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Poliomyelitis Vaccine Market Size by Company
        4.5.1 Top Poliomyelitis Vaccine Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Poliomyelitis Vaccine Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Poliomyelitis Vaccine Sales by Players (2020, 2021 & 2022)
5 Global Poliomyelitis Vaccine Market Size by Region
    5.1 Global Poliomyelitis Vaccine Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Poliomyelitis Vaccine Market Size in Volume by Region (2017-2028)
        5.2.1 Global Poliomyelitis Vaccine Sales in Volume by Region: 2017-2022
        5.2.2 Global Poliomyelitis Vaccine Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Poliomyelitis Vaccine Market Size in Value by Region (2017-2028)
        5.3.1 Global Poliomyelitis Vaccine Sales in Value by Region: 2017-2022
        5.3.2 Global Poliomyelitis Vaccine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Poliomyelitis Vaccine Market Size YoY Growth 2017-2028
        6.1.2 North America Poliomyelitis Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Poliomyelitis Vaccine Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Poliomyelitis Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Poliomyelitis Vaccine Market Size YoY Growth 2017-2028
        6.3.2 Europe Poliomyelitis Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Poliomyelitis Vaccine Market Size YoY Growth 2017-2028
        6.4.2 Latin America Poliomyelitis Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Poliomyelitis Vaccine Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Poliomyelitis Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 GSK
        7.1.1 GSK Corporation Information
        7.1.2 GSK Description and Business Overview
        7.1.3 GSK Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 GSK Poliomyelitis Vaccine Products Offered
        7.1.5 GSK Recent Development
    7.2 Sanofi-Pasteur
        7.2.1 Sanofi-Pasteur Corporation Information
        7.2.2 Sanofi-Pasteur Description and Business Overview
        7.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Sanofi-Pasteur Poliomyelitis Vaccine Products Offered
        7.2.5 Sanofi-Pasteur Recent Development
    7.3 Merck
        7.3.1 Merck Corporation Information
        7.3.2 Merck Description and Business Overview
        7.3.3 Merck Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Merck Poliomyelitis Vaccine Products Offered
        7.3.5 Merck Recent Development
    7.4 Crucell
        7.4.1 Crucell Corporation Information
        7.4.2 Crucell Description and Business Overview
        7.4.3 Crucell Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Crucell Poliomyelitis Vaccine Products Offered
        7.4.5 Crucell Recent Development
    7.5 China National Biotech Group
        7.5.1 China National Biotech Group Corporation Information
        7.5.2 China National Biotech Group Description and Business Overview
        7.5.3 China National Biotech Group Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 China National Biotech Group Poliomyelitis Vaccine Products Offered
        7.5.5 China National Biotech Group Recent Development
    7.6 Eli Lilly
        7.6.1 Eli Lilly Corporation Information
        7.6.2 Eli Lilly Description and Business Overview
        7.6.3 Eli Lilly Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Eli Lilly Poliomyelitis Vaccine Products Offered
        7.6.5 Eli Lilly Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Poliomyelitis Vaccine Industry Chain Analysis
    8.2 Poliomyelitis Vaccine Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Poliomyelitis Vaccine Distributors
    8.3 Poliomyelitis Vaccine Production Mode & Process
    8.4 Poliomyelitis Vaccine Sales and Marketing
        8.4.1 Poliomyelitis Vaccine Sales Channels
        8.4.2 Poliomyelitis Vaccine Distributors
    8.5 Poliomyelitis Vaccine Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Poliomyelitis Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Poliomyelitis Vaccine Market Trends
    Table 3. Poliomyelitis Vaccine Market Drivers
    Table 4. Poliomyelitis Vaccine Market Challenges
    Table 5. Poliomyelitis Vaccine Market Restraints
    Table 6. Global Poliomyelitis Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Poliomyelitis Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Poliomyelitis Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Poliomyelitis Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Poliomyelitis Vaccine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Poliomyelitis Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Poliomyelitis Vaccine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Poliomyelitis Vaccine Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Poliomyelitis Vaccine Sales Share by Manufacturer, 2017-2022
    Table 15. Global Poliomyelitis Vaccine Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Poliomyelitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Poliomyelitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliomyelitis Vaccine as of 2021)
    Table 18. Top Players of Poliomyelitis Vaccine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Poliomyelitis Vaccine Product Type
    Table 20. Date of International Manufacturers Enter into Poliomyelitis Vaccine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Poliomyelitis Vaccine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Poliomyelitis Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Poliomyelitis Vaccine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Poliomyelitis Vaccine Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Poliomyelitis Vaccine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Poliomyelitis Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Poliomyelitis Vaccine Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Poliomyelitis Vaccine Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Poliomyelitis Vaccine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Poliomyelitis Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Poliomyelitis Vaccine Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Poliomyelitis Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Poliomyelitis Vaccine Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Poliomyelitis Vaccine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Poliomyelitis Vaccine Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Poliomyelitis Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Poliomyelitis Vaccine Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Poliomyelitis Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Poliomyelitis Vaccine Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Poliomyelitis Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. GSK Corporation Information
    Table 43. GSK Description and Business Overview
    Table 44. GSK Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. GSK Poliomyelitis Vaccine Product
    Table 46. GSK Recent Development
    Table 47. Sanofi-Pasteur Corporation Information
    Table 48. Sanofi-Pasteur Description and Business Overview
    Table 49. Sanofi-Pasteur Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Sanofi-Pasteur Product
    Table 51. Sanofi-Pasteur Recent Development
    Table 52. Merck Corporation Information
    Table 53. Merck Description and Business Overview
    Table 54. Merck Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Merck Product
    Table 56. Merck Recent Development
    Table 57. Crucell Corporation Information
    Table 58. Crucell Description and Business Overview
    Table 59. Crucell Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Crucell Product
    Table 61. Crucell Recent Development
    Table 62. China National Biotech Group Corporation Information
    Table 63. China National Biotech Group Description and Business Overview
    Table 64. China National Biotech Group Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. China National Biotech Group Product
    Table 66. China National Biotech Group Recent Development
    Table 67. Eli Lilly Corporation Information
    Table 68. Eli Lilly Description and Business Overview
    Table 69. Eli Lilly Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Eli Lilly Product
    Table 71. Eli Lilly Recent Development
    Table 72. Key Raw Materials Lists
    Table 73. Raw Materials Key Suppliers Lists
    Table 74. Poliomyelitis Vaccine Customers List
    Table 75. Poliomyelitis Vaccine Distributors List
    Table 76. Research Programs/Design for This Report
    Table 77. Key Data Information from Secondary Sources
    Table 78. Key Data Information from Primary Sources
List of Figures
    Figure 1. Poliomyelitis Vaccine Product Picture
    Figure 2. Global Poliomyelitis Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Poliomyelitis Vaccine Market Size 2017-2028 (US$ Million)
    Figure 4. Global Poliomyelitis Vaccine Sales 2017-2028 (K Units)
    Figure 5. United States Poliomyelitis Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Poliomyelitis Vaccine Market Size 2017-2028 (US$ Million)
    Figure 7. United States Poliomyelitis Vaccine Sales 2017-2028 (K Units)
    Figure 8. United States Poliomyelitis Vaccine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Poliomyelitis Vaccine Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Poliomyelitis Vaccine Report Years Considered
    Figure 11. Product Picture of Poliomyelitis Vaccine Ⅰ
    Figure 12. Product Picture of Poliomyelitis Vaccine Ⅱ
    Figure 13. Product Picture of Poliomyelitis Vaccine Ⅲ
    Figure 14. Product Picture of Oral Poliomyelitis Vaccine
    Figure 15. Global Poliomyelitis Vaccine Market Share by Type in 2022 & 2028
    Figure 16. Global Poliomyelitis Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Poliomyelitis Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Poliomyelitis Vaccine Sales by Type (2017-2028) & (K Units)
    Figure 19. Global Poliomyelitis Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Poliomyelitis Vaccine Price by Type (2017-2028) & (USD/Unit)
    Figure 21. United States Poliomyelitis Vaccine Market Share by Type in 2022 & 2028
    Figure 22. United States Poliomyelitis Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Poliomyelitis Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Poliomyelitis Vaccine Sales by Type (2017-2028) & (K Units)
    Figure 25. United States Poliomyelitis Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Poliomyelitis Vaccine Price by Type (2017-2028) & (USD/Unit)
    Figure 27. Product Picture of VAPP
    Figure 28. Product Picture of VDPV
    Figure 29. Global Poliomyelitis Vaccine Market Share by Application in 2022 & 2028
    Figure 30. Global Poliomyelitis Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Poliomyelitis Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Poliomyelitis Vaccine Sales by Application (2017-2028) & (K Units)
    Figure 33. Global Poliomyelitis Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Poliomyelitis Vaccine Price by Application (2017-2028) & (USD/Unit)
    Figure 35. United States Poliomyelitis Vaccine Market Share by Application in 2022 & 2028
    Figure 36. United States Poliomyelitis Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Poliomyelitis Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Poliomyelitis Vaccine Sales by Application (2017-2028) & (K Units)
    Figure 39. United States Poliomyelitis Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Poliomyelitis Vaccine Price by Application (2017-2028) & (USD/Unit)
    Figure 41. North America Poliomyelitis Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 42. North America Poliomyelitis Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Poliomyelitis Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Poliomyelitis Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Poliomyelitis Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Poliomyelitis Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Poliomyelitis Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 65. Latin America Poliomyelitis Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Poliomyelitis Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Middle East & Africa Poliomyelitis Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Poliomyelitis Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Poliomyelitis Vaccine Value Chain
    Figure 75. Poliomyelitis Vaccine Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GSK
Sanofi-Pasteur
Merck
Crucell
China National Biotech Group
Eli Lilly
Frequently Asked Questions
Poliomyelitis Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Poliomyelitis Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Poliomyelitis Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports